03/24/2025
3:24 PM | Immunocore (Filer)
| Form PRE 14A | |
03/19/2025
5:40 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
3:24 PM | Di Donato Brian (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
7:18 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:04 AM | Immunocore (Filer)
| Form 424B7 | |
03/17/2025
5:48 AM | Immunocore (Filer)
| Form POSASR | |
03/10/2025
3:17 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:31 PM | Immunocore (Issuer)
Pao William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:00 AM | Immunocore (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2025
6:22 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
3:20 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for IMCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immunocore and its competitors with MarketBeat's FREE daily newsletter. |
02/13/2025
5:26 PM | Immunocore (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
| Form SCHEDULE 13G | |
01/10/2025
3:26 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:33 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:40 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/08/2024
3:20 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
6:22 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/16/2024
5:46 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
12:49 PM | Immunocore (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G | |
08/29/2024
6:21 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:21 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:06 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/30/2024
4:22 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
3:43 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
3:46 PM | Immunocore (Issuer)
KRISHANA RANJEEV (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
3:17 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:15 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Herbst Roy Steven (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:50 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:13 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024
3:35 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024
3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024
11:36 AM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Buy IMCR Stock Free IMCR Stock Alerts